Reddy Pharmaceuticals Limited, a active public limited company, was established on 05 January 1996 in Madhapur, Telangana, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232TG1996PLC116710. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.60 Cr and a paid-up capital of ₹2.60 Cr.
Formerly known as Reddy Pharmaceuticals Private Limited. It upholds a compliant status. Employing 1 professional, Its leadership includes Konda Raghurami Reddy (Director), Surya Kiran Reddy Konda (Director), Vishnu Vardhan Reddy Konda (Director). Past directors included Sivakumar Reddy Aluru, Jagan Mohan Nerusu, Konda Lalitha Reddy. It holds ₹0.50 M open charges and ₹4.35 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd Floor, Ayyanna Corporate, Plot No.350, Road No.8, Kakateeya Hills,, Madhapur, Telangana, 500081.
U24232TG1996PLC116710
116710
05 January 1996
₹2.60 Cr
₹2.60 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Reddy Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Konda Raghurami Reddy | Director | 05 Jan 1996 | Current |
| Surya Kiran Reddy Konda | Director | 30 Sep 2023 | Current |
| Vishnu Vardhan Reddy Konda | Director | 10 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2023 | Past |
| Pramod Abcsdd | Director | 28 Jul 2014 | Past |
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Director | 10 Feb 2016 | Past |
| Pramod Abcsdd | Director | 31 Mar 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Reddy Pharmaceuticals Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 89.65% decrease. The company also saw a substantial fall in profitability, with a 3310.3% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Reddy Pharmaceuticals had a promoter holding of 78.28% and a public holding of 21.72%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹43,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 1989 | P.N.B. | ₹0.50 M | Open |
| 24 Mar 2016 | Karnataka Bank Ltd. | ₹2.70 Cr | Satisfied |
| 15 Oct 2004 | Syndicate Bank | ₹1.65 Cr | Satisfied |
Explore comprehensive loan charge details -
Reddy Pharmaceuticals has a workforce of 1 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Reddy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reddy Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Reddy Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Reddy Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Surya Kiran Reddy Konda was appointed as a Director was appointed as a Director on 30 Sep 2023 & has been associated with this company since 2 years 3 months . was completed.
Progress on A charge registered on 24 Mar 2016 via Charge ID 100029147 with Karnataka Bank Ltd. was fully satisfied on 30 Sep 2020. was documented.
Progress on A charge with Karnataka Bank Ltd. of Rs. 2.70 Cr registered on 24 Mar 2016 with Charge ID 100029147 was modified on 11 Dec 2017. was documented.
Progress on A charge with Karnataka Bank Ltd. amounted to Rs. 2.70 Cr with Charge ID 100029147 was registered on 24 Mar 2016. was documented.
The CIN of Reddy Pharmaceuticals Limited is U24232TG1996PLC116710.
Reddy Pharmaceuticals Limited is headquartered at 2Nd Floor, Ayyanna Corporate, Plot No.350, Road No.8, Kakateeya Hills,, Madhapur, Telangana, 500081.
Reddy Pharmaceuticals Limited was incorporated on 05 January 1996.
The current directors of Reddy Pharmaceuticals Limited are
The primary industry of Reddy Pharmaceuticals Limited is Manufacturing.
Reddy Pharmaceuticals Limited is unlisted.
The authorized capital of Reddy Pharmaceuticals Limited is ₹2.60 Cr, and the paid-up capital is ₹2.60 Cr.
The compliance status of Reddy Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX